|
AU2015201280A1
|
|
Compositions and Methods for the Therapy and Diagnosis of Cytomegalovirus Infections
|
|
US2014328797A1
|
|
Human rhinovirus (hrv) antibodies
|
|
CA2909802A1
|
|
Compositions and methods for the therapy and diagnosis of influenza
|
|
US2015152166A1
|
|
Compositions and methods for the therapy and diagnosis of cytomegalovirus
|
|
AU2013206604A1
|
|
Compositions and Methods for the Therapy and Diagnosis of Influenza
|
|
WO2013033069A1
|
|
Human rhinovirus (hrv) antibodies
|
|
AU2012229188A1
|
|
Compositions and methods for the therapy and diagnosis of influenza
|
|
CN103687619A
|
|
Compositions and methods for the therapy and diagnosis of influenza
|
|
CA3109036A1
|
|
Human immunodeficiency virus (hiv)-neutralizing antibodies
|
|
AU2011289275A1
|
|
Anti-hemagglutinin antibody compositions and methods of use thereof
|
|
EP2464383A2
|
|
Compositions and methods for the therapy and diagnosis of influenza
|
|
US2011033476A1
|
|
Compositions and methods for the therapy and diagnosis of influenza
|
|
EP2432803A2
|
|
Compositions and methods for the therapy and diagnosis of influenza
|
|
CA2759506A1
|
|
Granulocyte-macrophage colony-stimulating factor (gm-csf) neutralizing antibodies
|
|
EP2408476A2
|
|
Human immunodeficiency virus (hiv) -neutralizing antibodies
|
|
TW201526913A
|
|
Compositions and methods for the therapy and diagnosis of influenza
|
|
TW201031420A
|
|
Compositions and methods for the therapy and diagnosis of influenza
|
|
CA2743306A1
|
|
Human m2e peptide immunogens
|
|
AU2009274502A1
|
|
Methods and compositions for discovery of target-specific antibodies using antibody repertoire array (ARA)
|
|
MX2010009885A
|
|
Compositions and methods for the therapy and diagnosis of cytomegalovirus infections.
|
